Search for: "Teva USA"
Results 341 - 360
of 714
Sort by Relevance
|
Sort by Date
20 Jan 2015, 8:48 am
By Jason Rantanen Teva Pharmaceuticals USA, Inc. v. [read post]
20 Jan 2015, 8:27 am
In Teva Pharmaceuticals USA, Inc. v. [read post]
20 Jan 2015, 7:14 am
The opinion in Teva Pharmaceuticals USA, Inc. v. [read post]
20 Jan 2015, 7:07 am
Breyer delivered the opinion of the Court in Teva Pharmaceuticals USA, Inc. v. [read post]
15 Jan 2015, 9:57 am
At its Conference on January 16, 2015, the Court will consider petitions seeking review of issues such as liability for a priest’s failure to report inappropriate sexual conduct, scope of the exhaustion requirement in a takings claim, the Heck v. [read post]
14 Jan 2015, 7:54 am
Marvel concerning the propriety of post-patent expiration royalties; The Supreme Court’s pending decision in Teva v. [read post]
5 Jan 2015, 1:26 pm
The prior published opinion in this case, Teva Pharmaceuticals USA, Inc. v. [read post]
3 Jan 2015, 9:41 am
On January 20, 2015, the Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
31 Dec 2014, 5:00 am
PLIVA USA, Inc., 741 F.3d 470 (4th Cir. 2014). [read post]
18 Dec 2014, 11:56 am
Supreme Court invitation brief in generic prescription drug failure to update warning label case initiated in California state court: You can access the CVSG brief filed today in Teva Pharmaceuticals USA, Inc. v. [read post]
7 Dec 2014, 9:03 pm
Teva Pharmaceuticals USA Inc. 1:14-cv-01451; filed December 2, 2014 in the District Court of Delaware • Plaintiffs: Reckitt Benckiser Pharmaceuticals Inc.; RB Pharmaceuticals Ltd.; MonoSol Rx LLC • Defendant: Teva Pharmaceuticals USA Inc. [read post]
5 Dec 2014, 9:00 am
Teva Pharmaceuticals USA, Inc., 731 F.3d 918 (9th Cir. 2013). [read post]
2 Dec 2014, 12:27 pm
Supreme Court heard argument six weeks ago in Teva Pharmaceuticals USA v. [read post]
10 Nov 2014, 2:18 pm
USA, Inc. v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
21 Oct 2014, 9:03 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
20 Oct 2014, 10:00 pm
Teva Pharmaceuticals, USA, Inc. [read post]
20 Oct 2014, 12:09 pm
On October 15, 2014, the Supreme Court heard oral argument inTeva Pharmaceuticals USA, Inc. v. [read post]
17 Oct 2014, 5:09 pm
Stephens Teva Pharmaceuticals USA, Inc., v. [read post]
17 Oct 2014, 7:23 am
At Bloomberg View, Noah Feldman analyzes Wednesday’s oral argument in the patent case Teva Pharmaceuticals USA v. [read post]
